The purpose of this pilot trial is to determine whether the addition of gait laboratory analysis for surgical decision making, compared with the use of observational analysis alone, results in improved functional outcomes in ambulatory children with cerebral palsy undergoing multi-level lower extremity orthopaedic surgery.
Children with cerebral palsy, who are ambulatory, have an inefficient gait often associated with functional disability. Many of these children are candidates for orthopaedic surgery, which includes multi-level soft tissue and bony procedures. Pre-operative planning is based on the physical examination and visual (observational) analysis of the child's gait. In some centres, patients undergo additional gait analysis in a motion laboratory. While gait laboratory analysis is accepted as an important research tool, there is controversy about its clinical utility in decision making for the surgical management of this population. To date, no clinical trials have been undertaken to answer this question, and the appropriate clinical utilization of this technology is yet to be established. The consequence of this uncertainty is that ambulatory children with cerebral palsy are either being deprived of a useful assessment tool in some centres, or alternatively they are being subjected to an unnecessary evaluation that is both expensive and time consuming in other centres. A multi-centre randomized trial will provide evidence to support or refute the need for gait laboratory analysis for surgical decision-making for this population. This pilot randomized controlled trial in four sites will assess the feasibility of, and provide the template for the design and conduct of the definitive larger multi-centred trial to extend its generalizability across North America and other jurisdictions. The specific objectives include: 1. Establish the feasibility of implementing the randomized trial study design in multiple centres 2. Estimate recruitment rates and timelines 3. Establish responsiveness of outcome measures to finalize the primary \& secondary outcomes 4. Estimate effect sizes of functional outcomes for sample size calculations 5. Establish data management system (web-based database) for definitive multi-centre study. 6. Assess feasibility, reliability and face validity of pilot health economic data forms to include health economic evaluation in the future definitive multi-centre trial. Secondary objectives include: 7. Does the addition of gait analysis alter surgical decisions made from video observation alone, when performed in the setting of this pilot trial? 8. Evaluate the consistency of the surgical decision making: intra- \& inter rater reliability
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
Controls will undergo the standard orthopaedic surgery using the information from the physical examination and observational analysis of the gait alone.
This experimental group will undergo standard orthopaedic surgery using the information from the physical examination, observational AND the gait laboratory analysis data
Glenrose Rehabilitation Hospital
Edmonton, Alberta, Canada
British Columbia's Children's Hospital
Vancouver, British Columbia, Canada
Erinoak Centre
Mississauga, Ontario, Canada
Grandview Children's Rehabilitation Centre
Oshawa, Ontario, Canada
General Effect Size of Secondary Outcomes
The final primary and secondary outcome measures will be chosen based on responsiveness and their effect sizes used to calculate sample size for a future definitive trial.
Time frame: Post Study
Gross Motor Function Measure (GMFM-66)
A well validated condition specific clinical measure to evaluate change in motor function in children with cerebral palsy
Time frame: Baseline, 6, 12, 24 months follow up
Pediatric Outcomes Data Collection Instrument(PODCI)
A generic measure of musculoskeletal functional health outcomes in children and adolescents
Time frame: Baseline, 6, 12, 24 months follow up
Gillette Functional Assessment Questionnaire (FAQ)
A validated condition specific functional walking scale developed for children with cerebral palsy
Time frame: Baseline, 6, 12, 24 months follow up
Functional Mobility Scale (FMS)
Developed to measure functional mobility of a child in three different environments (home, school, and the wider community).
Time frame: Baseline, 6, 12, 24 months follow up
Activity Scale for Kids (ASK)
A reliable and valid, self-report measure of childhood physical disability.
Time frame: Baseline, 6, 12, 24 months follow up
Gillette Gait (Normalcy) Index (GGI)
Quantifies the magnitude of gait deviation from normal
Time frame: Baseline, 6, 12, 24 months follow up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Bloorview Kids Rehab
Toronto, Ontario, Canada
The Hospital for Sick Children
Toronto, Ontario, Canada
Gait Parameters
Gait velocity; Stride length; O2 consumption \& O2 Cost during walking
Time frame: Baseline, 12-, 24-months follow-up